VAM
ASPX

Visium Asset Management’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Visium Asset Management’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-183,625
Closed -$4.71M – 1323
2014
Q3 		$4.71M Hold
183,625
– – 0.07% 285
2014
Q2 		$4.09M Sell
183,625
-50,000
-21% -$1.09M 0.06% 265
2014
Q1 		$7.19M Buy
+233,625
New +$6.28M 0.12% 172

Other funds holding ASPX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Visium Asset Management's ASPX Position: Q4 2014 in Review

Visium Asset Management sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q4 2014, closing a stake of 183,625 shares — an estimated $4.71M sold.

Visium Asset Management first reported a position in ASPX in Q1 2014 and held it in 3 quarters. The position peaked at $7.19M in Q1 2014. 89 funds tracked by Wall St. Rank hold ASPX as of Q4 2014.

  • Visium Asset Management reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • Visium Asset Management sold 183,625 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q4 2014, an estimated $4.71M.
  • Visium Asset Management first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 3 quarters.
  • Visium Asset Management's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $7.19M in Q1 2014.
  • 89 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q4 2014.

Based on Visium Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.